Drugmaker Sciwind has closed a $39 million Series B round led by LYFE Capital, while SDIC Unity Capital and Qiming Venture Partners have co-led a Series B round funding in Singular Medical.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
